Immunogenicity of the Quadrivalent Human Papillomavirus (Type 6/11/16/18) Vaccine in Males 16 to 26 Years Old

類似資料

• Safety and reactogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 viral-like-particle vaccine in older adolescents and young adults
  著者:: Moreira, Edson D, 等
  出版事項: (2011)
• Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males
  著者:: Giuliano, Anna R., 等
  出版事項: (2011)
• External Genital Human Papillomavirus Prevalence and Associated Factors Among Heterosexual Men on 5 Continents
  著者:: Vardas, Eftyhia, 等
  出版事項: (2011)
• Prevalence of and Risk Factors for Human Papillomavirus (HPV) Infection Among HIV-Seronegative Men Who Have Sex With Men
  著者:: Goldstone, Stephen, 等
  出版事項: (2011)
• End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of age
  著者:: Castellsagué, X, 等
  出版事項: (2011)